CS Diagnostics Corp. (CSDX)
OTCMKTS · Delayed Price · Currency is USD
0.1100
0.00 (0.00%)
Aug 25, 2025, 9:30 AM EDT
CS Diagnostics Revenue
CS Diagnostics had revenue of $70.42K in the quarter ending March 31, 2025. This brings the company's revenue in the last twelve months to $128.07K. In the year 2024, CS Diagnostics had annual revenue of $110.91K, down -12.00%.
Revenue (ttm)
128.07K
Revenue Growth
-12.00%
P/S Ratio
99.51
Revenue / Employee
128.07K
Employees
1
Market Cap
12.75M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 110.91K | -15.13K | -12.00% |
Dec 31, 2023 | 126.04K | - | - |
Dec 31, 2009 | - | - | - |
Dec 31, 2008 | - | - | - |
Dec 31, 2007 | 766.00 | -109.00 | -12.46% |
Dec 31, 2006 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2005 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2004 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2003 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2002 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
Glass House Brands | 221.55M |
Elite Pharmaceuticals | 105.45M |
Northwest Biotherapeutics | 1.09M |
American Oncology Network | 1.76B |
Silence Therapeutics | 27.17M |
Global Cord Blood | 196.10M |
CS Diagnostics News
- 6 weeks ago - CS Diagnostics Corp. Submitted Final Form-10 Registration Statement Draft to the processing team for preparation of Edgardization and filing with the U.S. Securities and Exchange Commission ("SEC") - Accesswire
- 2 months ago - CS Diagnostics Corp. to Present at the Small Cap Growth Virtual Investor Conference June 26th - GlobeNewsWire
- 2 months ago - CS Diagnostics Corp. CSDX to Present at the Small Cap Growth Virtual Investor Conference on June 26, 2025 at 12:30pm EDT - Accesswire
- 4 months ago - CS Diagnostics Corp. is Entering into a $5 Million Loan Agreement with SAN ART CAPITAL SAS - Accesswire
- 6 months ago - OTCQB-CSDX Appoints Lachman Consultants for CS-Protect Hydrogel FDA Approval - Accesswire
- 7 months ago - CS Diagnostics Corp. Announces U.S. Launch of MEDUSA - Business Wire